Table of Contents

company-logo

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

ProMIS Neurosciences Dividend Announcement

• ProMIS Neurosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on ProMIS Neurosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ProMIS Neurosciences Dividend History

ProMIS Neurosciences Dividend Yield

ProMIS Neurosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ProMIS Neurosciences stock? Use our calculator to estimate your expected dividend yield:

ProMIS Neurosciences Financial Ratios

P/E ratio-1.60
PEG ratio0.16
P/B ratio-8.60
ROE-407.51%
Payout ratio0.00%
Current ratio0.41
Quick ratio0.41
Cash Ratio0.31

ProMIS Neurosciences Dividend FAQ

Does ProMIS Neurosciences stock pay dividends?
ProMIS Neurosciences does not currently pay dividends to its shareholders.
Has ProMIS Neurosciences ever paid a dividend?
No, ProMIS Neurosciences has no a history of paying dividends to its shareholders. ProMIS Neurosciences is not known for its dividend payments.
Why doesn't ProMIS Neurosciences pay dividends?
There are several potential reasons why ProMIS Neurosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ProMIS Neurosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ProMIS Neurosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ProMIS Neurosciences a dividend aristocrat?
ProMIS Neurosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ProMIS Neurosciences a dividend king?
ProMIS Neurosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ProMIS Neurosciences a dividend stock?
No, ProMIS Neurosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ProMIS Neurosciences stocks?
To buy ProMIS Neurosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ProMIS Neurosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.